BIOSENSORS

Gross margin was 73% for FY 2012, compared to 75% for FY2011.

Net margin was bumped up in FY2012 because of a one-off "realisation of translation difference of investment in joint venture company" of US$237 million.

Gross margin was 81% for FY 2013 -- it's really a very profitable company. Hmmmm...maybe I should add more Biosensors stock to my portfolio this week, if it falls.

Biosensors trades at 13X PE and a market cap of S$1.9 billion. I think it's more attractive than its peer, MircroPort in HK.

MicroPort.... manufactures drug-eluting stents (and several other products for other medical treatment). It trades at 18X PE and market cap of about S$1.3 billion which is lower than Biosensors.

Do you guys know how much it costs to get a stent inserted in an artery in Singapore hospitals? It's anything between 3K and 21K. Depends mainly on what ward you get into.

www.moh.gov.sg/content/moh_web/home/cost...angioplastyptca.html

We certainly should do what it takes to avoid having to get in there!! Watch the fat, cholesterol, the calories....

Interesting to note the daily share buybacks are significant quantities.

Yes, there have been daily buybacks which were significant. However, I would be more inclined to view buying by CEO and other insider individuals much more positively than corporate buying.

Might be a good idea to buy some Biosensors ($1.045) before it announces an acquisition, assuming it is a great buy and earnings-accretive.

An acquisition is long awaited. The company didn't raise US$300 million thru a bond sale in Jan for nothing. And it is paying 4.875% interest.